ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Company Registration Number:
13787622 (England and Wales)

Unaudited abridged accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Contents of the Financial Statements

for the Period Ended 31 December 2023

Balance sheet
Notes

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Balance sheet

As at 31 December 2023


Notes

2023

13 months to 31 December 2022


£

£
Current assets
Stocks:   1,075
Debtors: 3 100
Cash at bank and in hand: 13,683 26,540
Total current assets: 13,783 27,615
Creditors: amounts falling due within one year: 4 (3,599) (5,983)
Net current assets (liabilities): 10,184 21,632
Total assets less current liabilities: 10,184 21,632
Total net assets (liabilities): 10,184 21,632
Capital and reserves
Called up share capital: 1 1
Profit and loss account: 10,183 21,631
Shareholders funds: 10,184 21,632

The notes form part of these financial statements

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Balance sheet statements

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

The members have agreed to the preparation of abridged accounts for this accounting period in accordance with Section 444(2A).

These accounts have been prepared in accordance with the provisions applicable to companies subject to the small companies regime.

The directors have chosen to not file a copy of the company’s profit & loss account.

This report was approved by the board of directors on 02 April 2024
and signed on behalf of the board by:

Name: Mrs B Rowley
Status: Director

The notes form part of these financial statements

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

1. Accounting policies

These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

Turnover policy

Turnover is measured at the fair value of the consideration received or receivable in respect of the provision of consultancy services, excluding discounts, rebates, value added tax or other similar sales taxes.

Other accounting policies

InventoriesWork in progress is valued at the net realisable value.

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

2. Employees

2023 13 months to 31 December 2022
Average number of employees during the period 1 1

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

3. Debtors

Debtors comprise of: Trade debtors - £100 (2022 - £nil)

ROWLEY CLINICAL RESEARCH CONSULTANCY LTD

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Creditors: amounts falling due within one year note

Taxation and social security - £2,475 (2022 - £5,074)Other creditors - £1,124 (2022 - £909)